Literature DB >> 20846340

Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.

Iryna Rusanova1, Germaine Escames, Gladys Cossio, Rosaura G de Borace, Belgica Moreno, Mariam Chahboune, Luís C López, Tomas Díez, Dario Acuña-Castroviejo.   

Abstract

OBJECTIVE: To correlate the clinical and hematological features of β-globin gene haplotypes with the oxidative stress status in pediatric patients with sickle cell disease (SCD).
METHODS: A total of 95 patients with SCD and 40 healthy children were studied. The β-globin cluster, plasma lipid peroxidation (LPO) and plasma nitrite plus nitrate (NOx), and erythrocyte content of glutathione (GSH) and glutathione disulfide (GSSG), and glutathione peroxidase (GPx), reductase (GRd), and superoxide dismutase (SOD) activities were measured.
RESULTS: Plasma LPO (P < 0.001) and NOx (P < 0.05) were significantly higher in patients than in controls. In erythrocytes of patients with SCD, the activities of GRd (P < 0.001) and SOD (P < 0.05) were lower, and the GSSG/GSH ratio (P < 0.001) and GPx activity (P < 0.001) were higher than in controls. High LPO levels and low SOD plus GRd activities were associated with increased severity of clinical manifestations, which correspond mainly to patients with Bantu and Benin haplotypes. LPO levels were reduced in patients with high fetal hemoglobin (HbF) levels, whereas the NOx levels and GRd activity tended to increase in this group.
CONCLUSION: Our results detected an important oxidative stress in patients with SCD and suggest that at least three redox markers, i.e., LPO, GRd, and SOD, were related with their clinical outcomes. Moreover, a relationship between high HbF and low LPO, and high HbF and high GRd activity and NOx levels were found.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846340     DOI: 10.1111/j.1600-0609.2010.01528.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  20 in total

1.  Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort.

Authors:  Betânia Lucena Domingues Hatzlhofer; Diego Antonio Pereira-Martins; Igor de Farias Domingos; Gabriela da Silva Arcanjo; Isabel Weinhäuser; Diego Arruda Falcão; Isabela Cristina Cordeiro Farias; Jéssica Vitória Gadelha de Freitas Batista; Luana Priscilla Laranjeira Prado; Jéssica Maria Florencio Oliveira; Thais Helena Chaves Batista; Marcondes José de Vasconcelos Costa Sobreira; Rodrigo Marcionilo de Santana; Amanda Bezerra de Sá Araújo; Manuela Albuquerque de Melo; Bruna Vasconcelos de Ancântara; Juan Luiz Coelho-Silva; Ana Beatriz Lucas de Moura Rafael; Danízia Menezes de Lima Silva; Flávia Peixoto Albuquerque; Magnun Nueldo Nunes Santos; Ana Cláudia Dos Anjos; Fernando Ferreira Costa; Aderson da Silva Araújo; Antonio Roberto Lucena-Araújo; Marcos André Cavalcanti Bezerra
Journal:  Ann Hematol       Date:  2021-02-13       Impact factor: 3.673

2.  Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.

Authors:  Tite M Mikobi; Prosper Lukusa Tshilobo; Michel N Aloni; Pierre Z Akilimali; Georges Mvumbi-Lelo; Jean Marie Mbuyi-Muamba
Journal:  J Clin Lab Anal       Date:  2017-01-23       Impact factor: 2.352

Review 3.  Inorganic nitrite therapy: historical perspective and future directions.

Authors:  Christopher G Kevil; Gopi K Kolluru; Christopher B Pattillo; Tony Giordano
Journal:  Free Radic Biol Med       Date:  2011-05-04       Impact factor: 7.376

4.  Study of correlation of nitrite levels with malonaldehyde and the prognosis of patients with sickle cell disease on hydroxyurea, Ceará-Brazil.

Authors:  Romélia Pinheiro Gonçalves; Darcielle Bruna Dias Elias; Hemerson Iury Ferreira Magalhães; Jacqueline Holanda de Souza
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

5.  Impact of oral L-arginine supplementation on blood pressure dynamics in children with severe sickle cell vaso-occlusive crisis.

Authors:  Richard Onalo; Antoinette Cilliers; Peter Cooper
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

6.  Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.

Authors:  Danilo Grunig Humberto Silva; Edis Belini Junior; Gisele Cristine de Souza Carrocini; Lidiane de Souza Torres; Octávio Ricci Júnior; Clarisse Lopes de Castro Lobo; Claudia Regina Bonini-Domingos; Eduardo Alves de Almeida
Journal:  BMC Med Genet       Date:  2013-10-09       Impact factor: 2.103

7.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 8.  Nitrate and periplasmic nitrate reductases.

Authors:  Courtney Sparacino-Watkins; John F Stolz; Partha Basu
Journal:  Chem Soc Rev       Date:  2014-01-21       Impact factor: 54.564

9.  Correlation of low levels of nitrite and high levels of fetal hemoglobin in patients with sickle cell disease at baseline.

Authors:  Darcielle Bruna Dias Elias; Lilianne Brito da Silva Rocha; Maritza Barbosa Cavalcante; Alano Martins Pedrosa; Izabel Cristina Bandeira Justino; Romélia Pinheiro Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea.

Authors:  Railson Henneberg; Michel Fleith Otuki; Aline Emmer Ferreira Furman; Priscila Hermann; Aguinaldo José do Nascimento; Maria Suely Soares Leonart
Journal:  Rev Bras Hematol Hemoter       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.